Cite
HARVARD Citation
O'Gorman, C. et al. (n.d.). P3‐020: AXS‐05, A NOVEL ORAL NMDA RECEPTOR ANTAGONIST WITH MULTI‐MODAL ACTIVITY IN CLINICAL DEVELOPMENT FOR AGITATION ASSOCIATED WITH ALZHEIMER'S DISEASE. Alzheimer's & dementia. p. P932. [Online].